thanks"A former market darling of the biotech sector, ChemGenex, is set to resume trading today after finalising a deal with Cephalon of about 70? a share".this is all I could get as I am not a subscriberanyone have the full article?
Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker